We have been working with Ataxia UK and the scientific community from around the world to advance research on DRPLA. Our recent article, published in a scientific journal, highlights the strides we and our scientific community have made in understanding DRPLA and our...
Dentatorubral-pallidoluysian atrophy (DRPLA) and Huntington's disease (HD) are rare genetic disorders affecting the brain, caused by a specific type of genetic change, an elongation of a repetitive stretch of the letters “C-A-G”. In DRPLA that expansion is found in...
On March 6-7, 2024, the International Drug Repurposing conference took place in Barcelona, bringing together nearly 200 attendees. Among them was Dr. Silvia Prades, our Research Manager, representing our commitment to advancing research. Drug repurposing consists of...
Rare Disease Day is a global movement to raise awareness about rare diseases and the challenges faced by those living with them. This day serves as a powerful reminder of the extraordinary resilience and spirit of the individuals worldwide living with a rare disease,...
In a study led by neurologist Silvia Grimaldi based in Trapani (Italy) and other professionals they reconstructed the largest family tree of DRPLA-affected individuals. Grimaldi and her collaborators investigated 6 apparently unrelated families with DRPLA, totaling 51...